Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?-Reference-Cited by-同舟云学术

Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?

Published:2023 Issue:8 Volume:19 Page:0
ISSN:0973-1482
Container-title:Journal of Cancer Research and Therapeutics
language:en
Short-container-title:J Can Res Ther

Author:

Korkmaz Mustafa,Eryılmaz MelekK,Koçak MehmetZ,Er MuhammedM,Hendem Engin,Demirkıran Aykut,Araz Murat,Karaağaç Mustafa,Artaç Mehmet

Publisher

Medknow

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference25 articles.

1. Epidemiology of renal cell carcinoma;Padala;World J Oncol,2020

2. Treatment of renal cell carcinoma: Current status and future directions;Barata;CA Cancer J Clin,2017

3. Reviewing treatment options for advanced renal cell carcinoma: Is there still a place for tyrosine kinase ınhibitor (TKI) monotherapy?;Fontes-Sousa;Adv Ther,2022

4. Clinical evaluation of red cell volume distribution width (RDW);Park;Yonsei Med J,1987

5. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia;Demir;Pediatr Int,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse;PLOS ONE;2024-08-01

2. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations;Clinical & Experimental Metastasis;2024-02-16

3. External Validation of a Red Cell-based Blood Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Treated With First- Line Immunotherapy Combinations;2023-10-10